Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Cycloserine Augmentation of Behavior Therapy for OCD
NCT00182000Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Nov 2003
- Primary completion
- Jan 2008
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 3 trial of d-cycloserine in obsessive compulsive disorder (OCD), sponsored by Massachusetts General Hospital. Started Nov 2003; status: completed.
02
Drugs
d-cycloserine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT00182000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182000.